Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study

European Journal of Endocrinology

Volumn 169, Issue 1, 2013, Pages 73-82

  Asvold, Bjørn Olav ^a,b   Bjøro, Trine ^c,d   Vatten, Lars J ^a,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THYROTROPIN; TRIGLYCERIDES;

EID: 84879921207     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0087     Document Type: Article

References (27)

1. Asvold BO, Bjøro T, Nilsen TI & Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. Journal of Clinical Endocrinology and Metabolism 2007 92 841-845. (doi:10.1210/jc.2006-2208)
2. Asvold BO, Vatten LJ, Nilsen TI & Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT study. European Journal of Endocrinology 2007 156 181-186. (doi:10.1530/eje.1.02333)
3. Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, Wareham NJ & Khaw KT. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clinical Endocrinology 2010 72 404-410. (doi:10.1111/j.1365-2265.2009.03640.x)
4. Garduno-Garcia Jde J, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. European Journal of Endocrinology 2010 163 273-278. (doi:10.1530/EJE-10-0312)
5. Iqbal A, Figenschau Y & Jorde R. Blood pressure in relation to serum thyrotropin: the Tromso study. Journal of Human Hypertension 2006 20 932-936. (doi:10.1038/sj.jhh.1002091)
6. Ittermann T, Thamm M, Wallaschofski H, Rettig R & Volzke H. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. Journal of Clinical Endocrinology and Metabolism 2012 97 828-834. (doi:10.1210/ jc.2011-2768)
7. Ittermann T, Tiller D, Meisinger C, Agger C, Nauck M, Rettig R, Hofman A, Franco O, Joergensen T, Linneberg A et al. High serum TSH levels are associated with current but not with incident hypertension. Thyroid 2013 in press. (doi:10.1089/thy.2012.0626)
8. Lee YK, Kim JE, Oh HJ, Park KS, Kim SK, Park SW, Kim MJ & Cho YW. Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean Journal of Internal Medicine 2011 26 432-439. (doi:10.3904/kjim.2011.26.4.432)
9. VolzkeH,AlteD,DorrM,Wallaschofski H, JohnU, Felix SB & Rettig R. The association between subclinical hyperthyroidism and blood pressure in a population-based study. Journal of Hypertension 2006 24 1947-1953. (doi:10.1097/01.hjh.0000244942.57417.8e)
10. Wang CY, Chang TC & Chen MF. Associations between subclinical thyroid disease and metabolic syndrome. Endocrine Journal 2012 59 911-917. (doi:10.1507/endocrj.EJ12-0076)
11. Wang F, Tan Y,Wang C, Zhang X, Zhao Y, Song X, Zhang B, Guan Q, Xu J, Zhang J et al. Thyroid-stimulating hormone levels within the reference range are associated with serumlipid profiles independent of thyroid hormones. Journal of Clinical Endocrinology andMetabolism 2012 97 2724-2731. (doi:10.1210/jc.2012- 1133)
12. Holmen J, Midthjell K, Krüger O, Langhammer A, Holmen TL, Bratberg GH, Vatten LJ & Lund-Larsen PG. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods, and participation. Norsk Epidemiologi 2003 13 19-32.
13. Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, Bratberg G, Heggland J & Holmen J. Cohort profile: the HUNT study, Norway. International Journal of Epidemiology 2013 in press. (doi:1093/ije/dys095)
14. Bjøro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L & Brochmann H. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trøndelag (HUNT). European Journal of Endocrinology 2000 143 639-647. (doi:10.1530/eje.0.1430639)
15. Kapelrud H, Frey H & Theodorsen L. Excretion of iodine in the urine. A study from 6 different Norwegian districts in 1985. Tidsskrift for Den Norske Laegeforening 1987 107 1320-1321, 1317.
16. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Volzke H et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Archives of Internal Medicine 2012 172 799-809. (doi:10.1001/archinternmed.2012.402)
17. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L & Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism 2005 90 4019-4024. (doi:10.1210/jc.2004-2225)
18. Reinehr T. Obesity and thyroid function. Molecular and Cellular Endocrinology 2010 316 165-171. (doi:10.1016/j.mce. 2009.06.005)
19. Svare A, Nilsen TI, Bjøro T, Asvold BO & Langhammer A. Serum TSH related to measures of body mass: longitudinal data from the HUNT study, Norway. Clinical Endocrinology 2011 74 769-775. (doi:10.1111/j.1365-2265.2011. 04009.x)
20. Asvold BO, Vatten LJ, Midthjell K & Bjøro T. Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT study in Norway. Journal of Clinical Endocrinology and Metabolism 2012 97 93-99. (doi:10.1210/jc.2011-1724)
21. SurksMI, Goswami G & Daniels GH. The thyrotropin reference range should remain unchanged. Journal of Clinical Endocrinology and Metabolism 2005 90 5489-5496. (doi:10.1210/jc.2005-0170)
22. Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, Satterfield S, Newman AB & Bauer DC. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clinical Endocrinology 2012 76 911-918. (doi:10.1111/j.1365- 2265. 2011.04328.x)
23. Park SB, Choi HC & Joo NS. The relation of thyroid function to components of the metabolic syndrome in Korean men and women. Journal of Korean Medical Science 2011 26 540-545. (doi:10.3346/jkms.2011.26.4.540)
24. Canaris GJ, Manowitz NR, Mayor G & Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine 2000 160 526-534. (doi:10.1001/archinte.160.4.526)
25. Cappola AR & Ladenson PW. Hypothyroidism and atherosclerosis. Journal ofClinicalEndocrinology andMetabolism2003882438-2444. (doi:10.1210/jc.2003- 030398)
26. Droyvold WB, Midthjell K, Nilsen TI & Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. International Journal of Obesity 2005 29 650-655. (doi:10.1038/sj.ijo.0802944)
27. Lavie CJ, Milani RV & Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology 2009 53 1925-1932. (doi:10.1016/ j.jacc.2008.12.068) Hospital